2024-06-21 PUT at $75.0 Option on Keros TherapeuticsInc
| KROS Stock | USD 46.87 0.56 1.21% |
2024-06-21 PUT at $75.0 is a PUT option contract on Keros TherapeuticsInc's common stock with a strick price of 75.0 expiring on 2024-06-21. The contract was last traded on 2024-02-07 at 11:03:46 for $24.0 and, as of today, has 18 days remaining before the expiration. The option is currently trading at a bid price of $26.8, and an ask price of $30.5. The implied volatility as of the 3rd of June is 139.92.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Keros TherapeuticsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Keros Stock please use our How to Invest in Keros TherapeuticsInc guide.
Keros |
A put option written on Keros TherapeuticsInc becomes more valuable as the price of Keros TherapeuticsInc drops. Conversely, Keros TherapeuticsInc's put option loses its value as Keros Stock rises. When exercised, put options on Keros TherapeuticsInc produce a short position in Keros Stock. Because of this protective nature, they are typically used either for hedging purposes or to capitalize on Keros TherapeuticsInc's downside price movement.
Rule 16 of 2024-06-21 Option Contract
The options market is anticipating that Keros TherapeuticsInc will have an average daily up or down price movement of about 8.74% per day over the life of the option. With Keros TherapeuticsInc trading at USD 46.87, that is roughly USD 4.1. If you think that the market is fully understating Keros TherapeuticsInc's daily price movement you should consider buying Keros TherapeuticsInc options at that current volatility level of 139.92%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
In The Money Put Option on Keros TherapeuticsInc
An 'In The Money' option is one with a strike price that the current stock price has already surpassed. Some options investors can hedge their Keros TherapeuticsInc positions using in-the-money options. They may also want to buy options with some intrinsic value, not just time value. However, because in-the-money options on Keros Stock have intrinsic value and are priced higher than out-of-the-money options in the same chain, their volatilities are relatively smaller.
| Put Contract Name | 2024-06-21 PUT at $75.0 |
| Expires On | 2024-06-21 |
| Days Before Expriration | 18 |
| Last Traded On | 2024-02-07 11:03:46 |
| Contract Period | MONTHLY |
| Open Interest | 3 |
| Current Trading Volume | 0.0 |
| Strike Price | 75.0 |
| Last Traded At | 24.0 |
| Current Price Spread | 26.8 | 30.5 |
| Rule 16 Daily Up or Down | USD4.1 |
Keros short PUT Option Greeks
Keros TherapeuticsInc's Option Greeks for the contract ending on 2024-06-21 at a strike price of 75.0 measures the various factors that affect its cost and calculated using a theoretical options pricing model. It helps investors make more informed decisions about whether to trade this option contract or when to trade it. In addition to Keros TherapeuticsInc's option greeks, its implied volatility helps estimate the risk of Keros TherapeuticsInc stock implied by the prices of the options on Keros TherapeuticsInc's stock.
| Delta | -0.9015 | |
| Gamma | 0.0115 | |
| Theta | -0.0604 | |
| Vega | 0.0189 | |
| Rho | -0.0216 |
Keros long PUT Option Payoff at expiration
Put options written on Keros TherapeuticsInc grant holders of the option the right to sell a specified amount of Keros TherapeuticsInc at a specified price within a specified time frame. The put buyer has a limited loss and, while not fully unlimited gains, as the price of Keros Stock cannot fall below zero, the put buyer does gain as the price drops. So, purchasing a put option on Keros TherapeuticsInc is like buying insurance aginst Keros TherapeuticsInc's downside shift.
Profit |
| Keros TherapeuticsInc Price At Expiration |
Keros short PUT Option Payoff at expiration
By selling Keros TherapeuticsInc's put option, the investors signal their bearish sentiment. A short position in a put option written on Keros TherapeuticsInc will generally make money when the underlying price is above the strike price. Therefore Keros TherapeuticsInc's put payoff at expiration depends on where the Keros Stock price is relative to the put option strike price. The breakeven price of 46.35 is the critical point that divides the payoff function into two parts. Below the breakeven price, the payoff is dropping and negative (the seller makes a loss). Above the breakeven price, the payoff line is upward sloping as the option payoff increases in proportion to Keros TherapeuticsInc's price. Finally, at the strike price of 75.0, the payoff chart is constant and positive.
Profit |
| Keros TherapeuticsInc Price At Expiration |
Keros TherapeuticsInc Available Put Options
Keros TherapeuticsInc's option chain is a display of a range of information that helps investors for ways to trade options on Keros. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Keros. It also shows strike prices and maturity days for a Keros TherapeuticsInc against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
| Delta | Gamma | Open Int | Expiration | Current Spread | Last Price | |||
Put | 2024-06-21 PUT at $40.0 | -0.2598 | 0.0204 | 159 | 2024-06-21 | 1.0 - 5.0 | 1.0 | Out |
Put | 2024-06-21 PUT at $45.0 | -0.3846 | 0.0278 | 6 | 2024-06-21 | 2.65 - 6.2 | 3.9 | Out |
Put | 2024-06-21 PUT at $50.0 | -0.5325 | 0.0302 | 18 | 2024-06-21 | 5.1 - 9.3 | 7.05 | In |
Put | 2024-06-21 PUT at $55.0 | -0.6486 | 0.0266 | 8 | 2024-06-21 | 8.7 - 13.0 | 2.72 | In |
Put | 2024-06-21 PUT at $60.0 | -0.7271 | 0.0222 | 205 | 2024-06-21 | 12.5 - 17.0 | 15.17 | In |
Put | 2024-06-21 PUT at $65.0 | -0.8373 | 0.0183 | 2 | 2024-06-21 | 17.1 - 21.0 | 7.9 | In |
Put | 2024-06-21 PUT at $70.0 | -0.8813 | 0.0142 | 0 | 2024-06-21 | 21.5 - 26.0 | 0.0 | In |
Put | 2024-06-21 PUT at $75.0 | -0.9015 | 0.0115 | 3 | 2024-06-21 | 26.8 - 30.5 | 24.0 | In |
Put | 2024-06-21 PUT at $80.0 | -0.918 | 0.0096 | 0 | 2024-06-21 | 31.6 - 35.5 | 0.0 | In |
Put | 2024-06-21 PUT at $85.0 | -0.9283 | 0.0081 | 0 | 2024-06-21 | 36.5 - 40.5 | 0.0 | In |
Put | 2024-06-21 PUT at $90.0 | -0.9433 | 0.0066 | 0 | 2024-06-21 | 41.3 - 45.5 | 0.0 | In |
Put | 2024-06-21 PUT at $95.0 | -0.9343 | 0.0067 | 0 | 2024-06-21 | 46.5 - 50.5 | 0.0 | In |
Put | 2024-06-21 PUT at $100.0 | -0.9363 | 0.0062 | 0 | 2024-06-21 | 51.5 - 55.5 | 0.0 | In |
Put | 2024-06-21 PUT at $105.0 | -0.938 | 0.0058 | 0 | 2024-06-21 | 56.5 - 60.5 | 0.0 | In |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Keros TherapeuticsInc without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Headlines Timeline Now
Headlines TimelineStay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
| All Next | Launch Module |
Keros TherapeuticsInc Corporate Management
Elected by the shareholders, the Keros TherapeuticsInc's board of directors comprises two types of representatives: Keros TherapeuticsInc inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Keros. The board's role is to monitor Keros TherapeuticsInc's management team and ensure that shareholders' interests are well served. Keros TherapeuticsInc's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Keros TherapeuticsInc's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Robin Wagner | Senior Resources | Profile | |
| Simon MBBS | Chief Officer | Profile | |
| Keith MBA | Chief Officer | Profile | |
| Christopher MSc | Chief Officer | Profile | |
| John MBA | Senior Management | Profile | |
| Jennifer Lachey | Chief Officer | Profile | |
| Jasbir Seehra | CEO and President | Profile |
Already Invested in Keros TherapeuticsInc?
The danger of trading Keros TherapeuticsInc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Keros TherapeuticsInc is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Keros TherapeuticsInc. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Keros TherapeuticsInc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Keros TherapeuticsInc is a strong investment it is important to analyze Keros TherapeuticsInc's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Keros TherapeuticsInc's future performance. For an informed investment choice regarding Keros Stock, refer to the following important reports: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Keros TherapeuticsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Keros Stock please use our How to Invest in Keros TherapeuticsInc guide.You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Complementary Tools for Keros Stock analysis
When running Keros TherapeuticsInc's price analysis, check to measure Keros TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Keros TherapeuticsInc is operating at the current time. Most of Keros TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Keros TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Keros TherapeuticsInc's price. Additionally, you may evaluate how the addition of Keros TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |
Is Keros TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Keros TherapeuticsInc. If investors know Keros will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Keros TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.15) | Revenue Per Share 0.007 | Return On Assets (0.26) | Return On Equity (0.40) |
The market value of Keros TherapeuticsInc is measured differently than its book value, which is the value of Keros that is recorded on the company's balance sheet. Investors also form their own opinion of Keros TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Keros TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Keros TherapeuticsInc's market value can be influenced by many factors that don't directly affect Keros TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Keros TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Keros TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Keros TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.